While these ApoE mouse models do not have typical pathologies for either tau or Aβ, our study illustrated that mCRP plays a role in causing cerebrovascular inflammation, which is an early‐stage risk for AD, through in an ApoE4‐related pathway (Figures 2, 3 and 5). Here, MAPT is linked to Alzheimer disease.